The program would pair licensed drone carriers with Arrive Points to bring secure, autonomous pharmacy delivery to Indianapolis-area patients

INDIANAPOLIS, IN / ACCESS Newswire / August 4, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today announced it has signed a letter of intent ("LOI") with LifeSpan Pharmacy, LLC, an Indianapolis-based pharmacy provider, to explore a collaborative program to develop and deploy an autonomous, drone-based pharmacy delivery network.

Under the terms of the LOI, the parties intend to pursue a phased approach. The initial phase is expected to include a live demonstration flight from LifeSpan Pharmacy's facility to a nearby recipient, delivering actual pharmaceuticals and validating the delivery corridor. Subsequent phases, subject to mutual agreement, would progress through pilot corridor buildout, expansion across priority delivery zones, and potential full deployment supporting on-demand, autonomous pharmacy delivery across LifeSpan's service area.